Ziorel Plus

Quick links to important sections

Ziorel Plus

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ziorel Plus

What is Ziorel Plus?

Ziorel Plus is a fixed-dose combination medication used in the management of hypertension (high blood pressure). It contains two active pharmacological agents: telmisartan and hydrochlorothiazide. These components work through different physiological pathways to help lower systemic blood pressure more effectively than either agent used alone.

Components and Mechanism of Action

The effectiveness of Ziorel Plus is derived from the synergistic action of its two primary ingredients:

  • Telmisartan: This belongs to a class of drugs known as angiotensin II receptor blockers (ARBs). It works by blocking the action of angiotensin II, a natural substance in the body that causes blood vessels to tighten and narrow. By inhibiting this process, telmisartan allows blood vessels to relax and widen, which facilitates smoother blood flow.
  • Hydrochlorothiazide: This is a thiazide diuretic, often referred to as a "water pill." It acts on the kidneys to increase the removal of excess salt and water from the body through urine. Reducing the total volume of fluid circulating in the bloodstream decreases the pressure exerted on the arterial walls.

Therapeutic Purpose

Ziorel Plus is typically utilized when a single medication is insufficient to achieve targeted blood pressure levels. By addressing blood pressure through both the hormonal system (renin-angiotensin system) and fluid volume regulation, the medication helps reduce the workload on the heart and may decrease the long-term risks associated with untreated hypertension, such as cardiovascular complications.

Regulatory References

  1. Avalide (irbesartan/hydrochlorothiazide) DailyMed Label
  2. NIH DailyMed Official Website
  3. Hydrochlorothiazide MedlinePlus Drug Information

What side effects are possible with Ziorel Plus?

Possible Side Effects and Safety Information

The safety profile for Ziorel Plus (Irbesartan/Hydrochlorothiazide) is defined by official regulatory documents, which classify adverse reactions primarily by frequency and the body system affected. These classifications structure the understanding of possible risks, ranging from commonly expected reactions to rare, serious events. This section is strictly descriptive of the official regulatory safety data.


Official Adverse Reaction Categories

Adverse reactions are grouped by System-Organ-Classes (SOC), including the Nervous System Disorders (e.g., dizziness, headache, vertigo), Gastrointestinal Disorders (e.g., nausea, vomiting, diarrhea), and effects on Metabolism and Nutrition Disorders (e.g., fluid and electrolyte imbalance).

Commonly documented adverse events include dizziness, headache, and fatigue. Orthostatic effects, such as dizziness when standing, are also commonly reported and may be more pronounced at the beginning of treatment or when the dose is increased.


Clinically Significant and Serious Reactions

Official labeling documents certain serious adverse reactions. These include Angioedema (severe swelling of the face, lips, and tongue) and Severe Hypotension (a profound drop in blood pressure). The Hydrochlorothiazide component is also associated with rare, severe events like Acute Respiratory Distress Syndrome (ARDS) and specific ocular events, such as acute myopia and secondary angle-closure glaucoma.


Population-Specific Safety Constraints

Ziorel Plus is contraindicated for use in the second and third trimesters of pregnancy due to the risk of fetal harm. It is also contraindicated in patients with pre-existing conditions such as anuria (absence of urine formation), known hypersensitivity to sulfonamide-derived drugs, and severe hepatic impairment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile of Ziorel Plus (Irbesartan/Hydrochlorothiazide) based on two major physiological disturbances: excessive lowering of blood pressure and severe fluid and electrolyte imbalance.

Overdose manifestations primarily include severe Hypotension (low blood pressure), which may lead to fainting (syncope), and alterations in heart rhythm, such as Tachycardia or Bradycardia. Symptoms related to severe Volume Depletion and Electrolyte Imbalance are also documented, including lethargy, confusion, muscle cramps, and laboratory findings like Hypokalaemia (low potassium) and Hyponatraemia (low sodium).

Severe outcomes listed in official prescribing information include Cardiac Arrhythmias secondary to electrolyte imbalance, Acute Renal Failure, and Seizures.

Action Required (Official Guidance) Condition Mandating Action
Seek immediate medical attention Any suspected overdose, regardless of symptoms.
Call emergency services immediately Collapse, seizure, trouble breathing, or unresponsiveness.

Management is strictly symptomatic and supportive. Regulatory statements confirm that no specific antidote is known. Procedures include correcting fluid deficits, such as the use of intravenous infusion of normal saline, and administering activated charcoal to limit drug absorption.

Therapeutic Uses of Ziorel Plus

What Ziorel Plus Treats: Main Uses and Benefits

Ziorel Plus is commonly used to help manage blood pressure levels (hypertension). This function contributes to reducing the risk of serious future health issues, such as stroke and heart attack, and supports general well-being during symptomatic phases. The medication may also assist with managing the progression of diabetic kidney disease (nephropathy) in patients with Type 2 Diabetes and high blood pressure.

The primary therapeutic applications include managing high blood pressure and providing support for kidney function in certain patients with diabetes.

“This medication is applied across therapeutic domains involving chronic systemic management, where ongoing support is needed to maintain functional stability.”

By helping to manage blood pressure in this group, Ziorel Plus may offer supportive relief relevant for managing the condition’s systemic impact. Its use generally contributes to improved day-to-day comfort by managing risks that are often linked to systemic imbalance.


Quick Fact: Relief for Symptoms related to Systemic Imbalance


Eligibility and Restrictions for Use

Ziorel Plus is a fixed-dose combination of irbesartan and hydrochlorothiazide. Eligibility for this medicine is strictly defined by regulatory documents based on specific clinical and physiological states. The medicine is contraindicated and must not be used in several patient groups:

Classification Population/Condition
Absolute Contraindication Known hypersensitivity to irbesartan, hydrochlorothiazide, or any sulfonamide-derived drugs.
Absolute Contraindication Patients experiencing anuria (inability to produce urine).
Absolute Contraindication Pregnancy (especially the second and third trimesters) or planning to become pregnant. Treatment must be stopped immediately if pregnancy is detected.
Absolute Contraindication Concomitant use with any aliskiren-containing medicine in patients with diabetes mellitus.

Use Limitations and Restrictions

  • Pediatric Use: The product is not recommended for use in children and adolescents (under 18 years), as safety and efficacy have not been established by regulatory authorities.
  • Renal Function: It is not recommended for patients with severe renal impairment (creatinine clearance le 30 mL/min). Normal use is allowed for those with mild-to-moderate impairment.
  • Lactation: The medicine is not recommended for use while breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information documents specific interaction patterns for Ziorel Plus (Irbesartan/Hydrochlorothiazide) with other medicines and substances. The combination is contraindicated with Aliskiren-containing medicines in patients with diabetes or renal impairment (GFR less than 60 mL/ min), as this represents a dual blockade of the Renin-Angiotensin System (RAS).

Other significant interactions are primarily pharmacodynamic or exposure-modifying.

Interacting Substance Official Interaction Outcome
Lithium Increases serum Lithium concentrations and risk of toxicity.
NSAIDs (incl. COX-2 inhibitors) May reduce antihypertensive effect and increase risk of renal impairment.
Potassium-sparing Diuretics / Potassium Supplements Increased risk of hyperkalemia (high potassium levels).

For products that interfere with absorption, such as Cholestyramine or Colestipol resins, regulatory labels require specific administration timing: Ziorel Plus must be taken 4 hours before or 4 hours after these resins to ensure the full effect of the hydrochlorothiazide component. The combination with Alcohol, Barbiturates, or Narcotics is documented to increase the risk of orthostatic hypotension.

Mechanism of Action

Modulation of Receptor-Mediated Signaling

Ziorel Plus exerts its pharmacodynamic effects by primarily engaging specific membrane receptors within defined biological systems. It functions as a selective modulator of receptor-mediated signaling, binding to its target site to either initiate or suppress the associated intracellular signaling sequences. This molecular interaction represents an early step in the overall cascade, directly modifying the transmission of signals and influencing the subsequent molecular events that shape systemic physiological outcomes.


Regulation of High-Activity Signaling Processes

The drug engages mechanisms that influence processes characterized by elevated signaling flux. Through its action on the upstream receptors, Ziorel Plus acts to alter pathway activity, effectively reducing the concentration or activity of specific physiological mediators involved in rapid communication. This intervention promotes the re-establishment of basal signaling flux within targeted pathways, ultimately resulting in observable changes to baseline physiological parameters.

Dosage and Administration Information

Instruction Map: How to use Ziorel Plus — Official Administration Guidelines

Ziorel Plus is a fixed-dose combination product containing the active ingredients Irbesartan and Hydrochlorothiazide. The following instructions detail the standardized administration procedure for this combination product.


Administration Scope

Feature Official Instruction
Route of administration Oral (swallowed)
Dosing schedule Typically one tablet once daily.
Timing in relation to meals May be taken with or without food.
Preparation requirements None. The tablet must be swallowed whole.
Age-group administration rules For use in adults (patients 18 years of age and older).
Missed-dose rules If a dose is missed, the patient should take the next scheduled dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Special procedural conditions Use a sufficient amount of water when swallowing the tablet.

Instruction Classifications (High-Level)

Classification Rule
Administration method type Oral
Frequency pattern Daily (Once per 24 hours)
Regulatory basis Based on standardized labeling for the active combination (Irbesartan/HCTZ).
Use-context constraints Requires regular, scheduled daily administration for protocol adherence.

Resulting Procedural Structure

Official step sequence:

  • Take the specified strength tablet (e.g., 150 mg/12.5 mg or 300 mg/12.5 mg).
  • Swallow the tablet whole; it must not be crushed or chewed.
  • Administer the dose once every day, at a consistent time.

Connection to the overall use protocol: The official instructions establish a standardized, once-daily oral procedure that defines the dose, the method of ingestion (swallowing whole), and the required frequency for using the medicine. This protocol dictates that the dose must be maintained daily without adjustment for food intake and includes the rule that a missed dose should not be compensated for by doubling the next scheduled dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Ziorel Plus

Evidence for Use in Essential Hypertension (High Blood Pressure)

The primary research for Ziorel Plus was studied in research contexts for essential hypertension (high blood pressure) and relies on randomized, controlled clinical trials (RCTs). Researchers examined outcomes related to physiological strain or stress, specifically measuring changes in two main metrics of blood pressure: Seated Systolic Blood Pressure (SeSBP) and Seated Diastolic Blood Pressure (SeDBP). These studies were generally conducted over short-term periods, typically lasting 8 to 12 weeks, and mainly involved adult patients with mild-to-moderate high blood pressure.

Findings describe patterns observed in measured outcomes when using the combination compared to its individual components. Research examined the measured blood pressure changes when using the combination compared to using either ingredient alone. However, these primary trials focusing on blood pressure metrics were of a short duration. This means that long-term effects are not fully established directly by these initial studies, and results apply only to the populations studied.

Research Studies for Diabetic Kidney Disease

The combination was also evaluated in research contexts involving patients with Type 2 Diabetes and high blood pressure, focusing on outcomes related to diabetic kidney disease (nephropathy). The research for this context primarily relies on long-term randomized controlled trials conducted using the Irbesartan monotherapy component. These studies monitored changes in the amount of protein (albuminuria) in the urine and the rate at which kidney function evolved over follow-up periods that extended for several years.

Regulatory assessment reviews the reported patterns of blood pressure changes associated with the combination, alongside the known research for the Irbesartan component alone. Data specific to the fixed-dose combination (FDC) for kidney end-points are still emerging, and comparative evidence is lacking from dedicated trials evaluating the FDC against monotherapy for these outcomes.

What Remains Unclear or Requires Further Research

Research examined findings in various subgroup populations, including older adults and patients characterized by obesity, but sample sizes were modest in some of these analyses. Long-term effects are not fully established regarding the combination's impact on preventing hard cardiovascular events over periods of several years. Comparative evidence is lacking from dedicated trials that evaluate the FDC against all other common dual-therapy options for high blood pressure. Research is ongoing to help clarify these points, but study results reflect the specific conditions under which they were conducted.

Frequently Asked Questions (FAQ)

Common questions about Ziorel Plus (FAQ)


Q: Does Ziorel Plus contain a steroid or an opioid?

A: Ziorel Plus is a fixed-dose combination containing the active ingredients Irbesartan and Hydrochlorothiazide, which belong to the ARB and diuretic drug classes. Official regulatory documents list the components and do not specify that the product contains any opioid or steroid substances.


Q: Why is Ziorel Plus prescribed for so many different conditions?

A: The official product information lists its use for treating essential hypertension (high blood pressure). It is also indicated in contexts related to managing high blood pressure in patients who also have Type 2 Diabetes and associated kidney disease.


Q: How quickly should someone expect to feel the effects of Ziorel Plus?

A: According to official prescribing information, the full blood pressure lowering effects of Ziorel Plus are typically reached over time. Maximum results are generally observed within a period of two to four weeks after any dose adjustment is implemented.


Q: Are the side effects of Ziorel Plus serious or just annoying?

A: Official documentation groups adverse reactions into categories that cover a range of risks. This includes frequently reported effects like dizziness and headache, as well as less common but clinically significant reactions such as angioedema or severe hypotension.


Q: Do people experience weight gain when taking Ziorel Plus?

A: Official reports document weight gain as an uncommon side effect of Ziorel Plus. This means the event has been reported in a small percentage (0.1% to 1%) of patients in official documentation.


Q: Can Ziorel Plus cause mood changes or depression?

A: The medicine can influence the balance of fluid and electrolytes in the body, according to regulatory information. Mood changes have been noted as a possible sign or symptom related to these metabolic imbalances.


Q: Is it common for Ziorel Plus to cause drowsiness during the day?

A: Official documents report that somnolence, or drowsiness, is documented as an uncommon side effect. This is classified under nervous system disorders in regulatory reports.


Q: Can Ziorel Plus be taken with common pain relievers like Advil?

A: Regulatory information notes that the co-administration of NSAIDs (a drug class that includes some common pain relievers) may be associated with a reduced blood pressure lowering effect. This combination may also increase the risk of renal impairment.


Q: Is it okay to have a glass of wine while on Ziorel Plus?

A: The official labeling documents that taking Ziorel Plus with alcohol increases the risk of orthostatic hypotension. This is a sudden drop in blood pressure that can cause dizziness when standing up.


Q: Can Ziorel Plus be taken by the elderly?

A: Official instructions specify that Ziorel Plus is for use in adults (18 years and older). Clinical studies have included the examination of patterns observed in older adult populations.


Q: Are there any specific foods that should be avoided while taking Ziorel Plus?

A: The medicine can be taken with or without food. Official information advises that the use of salt substitutes that contain potassium should be noted, as the drug can influence potassium levels in the body.


Q: Can taking Ziorel Plus affect the results of lab tests?

A: According to official reports, the medicine can be associated with changes in laboratory values. This includes increases in markers like BUN and creatinine, and changes in serum potassium and sodium levels.


Q: Are there any long-term side effects of Ziorel Plus that are still being studied?

A: Research summaries state that the long-term effects of the fixed-dose combination, specifically regarding the prevention of hard cardiovascular events over many years, are not fully established. This is a focus point for ongoing studies.


Q: Why do official documents advise caution when driving on Ziorel Plus?

A: Official information advises caution with driving or operating machinery. This is because the drug may cause dizziness or drowsiness in some patients.


Q: Is Ziorel Plus generally considered a first-line treatment for its primary indication?

A: Official prescribing information notes that Ziorel Plus is typically indicated for patients whose blood pressure has not been adequately controlled on monotherapy (treatment with a single drug).


Q: Is it normal to feel a bit restless when first starting Ziorel Plus?

A: Restlessness is documented as a side effect in official reports.


Q: Can Ziorel Plus affect sleep patterns?

A: Official documents report that trouble sleeping (insomnia) has been noted as a side effect of Ziorel Plus.


Q: Does Ziorel Plus interact with any common over-the-counter cold medicines?

A: The medicine has documented interactions with the drug class NSAIDs, which are present in some over-the-counter cold medicines. The drug is also associated with a risk of orthostatic hypotension when combined with alcohol, a component of some liquid cold remedies.

How should Ziorel Plus be stored and disposed of?

How to Store and Dispose of Ziorel Plus?

The official storage and disposal guidelines for Ziorel Plus are mandated to maintain its quality and protect the environment.


Official Storage Requirements

Storage Condition Mandatory Requirement
Temperature Store at Controlled Room Temperature (15 C to 30 C).
Protection Keep tightly closed in the original container, away from excess heat, moisture, and direct light.
Prohibited Do not freeze.
Child Safety Keep out of the sight and reach of children.

Disposal Protocol

Ask a pharmacist or healthcare professional for guidance on disposing of unused or expired Ziorel Plus. The preferred method is to use a drug take-back program. If a take-back option is unavailable, the medicine may be disposed of in the household trash after mixing with an undesirable substance. Do not flush the medication down the toilet or throw it into wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ziorel Plus found in:

A-Z Index: